Image

Visual Plasticity Following Brain Lesions

Visual Plasticity Following Brain Lesions

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways. It aims to investigate whether transcranial random noise stimulation (tRNS) combined with perceptual learning-based training has potential for improving visual impairments.

Eligibility

  1. Stroke, brain tumor, or traumatic brain injury patients

Inclusion Criteria:

  1. At least 18 years of age.
  2. Capable of providing informed consent and complying with study procedures.
  3. Unilateral or bilateral focal brain damage causing loss of vision.
  4. At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.

Exclusion Criteria:

  1. Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
  2. Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
  3. Vision loss resulting from ocular disease or disorder.
  4. Healthy volunteers (age-matched controls):

Inclusion Criteria:

  1. At least 18 years of age.
  2. Capable of providing informed consent and complying with study procedures.

Exclusion Criteria:

  1. Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.
  2. Previous head injury.
  3. Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5.

Study details
    Visual Field Defect
    Stroke
    Hemianopia
    Quadrantanopia
    Cortical Blindness
    Brain Tumor
    Traumatic Brain Injury
    Visual Field Defect
    Peripheral

NCT07105358

Georgetown University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.